TARGET THERAPEUTICS, INC. – Trademark Portfolio
Entity Type: 03
TARGET THERAPEUTICS, INC. holds 70 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 70 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include 1018, CONTOUR, and HYDROLENE. The owner is based in FREMONT, CA.
POST OFFICE BOX 5120
47201 LAKEVIEW BLVD.
FREMONT, CA 49537
Showing of trademarks Trademarks
Trademark Classifications
TARGET THERAPEUTICS, INC.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Frequently Asked Questions
How many trademarks does TARGET THERAPEUTICS, INC. have?
TARGET THERAPEUTICS, INC. has 70 U.S. trademarks filed with the USPTO. Of these, 3 registered, 28 abandoned, 39 cancelled.
What trademark classes does TARGET THERAPEUTICS, INC. file in?
TARGET THERAPEUTICS, INC. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are TARGET THERAPEUTICS, INC.'s most well-known trademarks?
TARGET THERAPEUTICS, INC.'s registered trademark portfolio includes well-known marks such as 1018, CONTOUR, and HYDROLENE. These are among 3 currently registered trademarks in the portfolio.
What is TARGET THERAPEUTICS, INC.'s trademark registration success rate?
TARGET THERAPEUTICS, INC. has a 4% trademark registration rate, with 3 out of 70 resolved applications resulting in successful registration. Currently, 0 applications are pending review.